James F. Oliviero III

2018

In 2018, James F. Oliviero III earned a total compensation of $2.1M as Chief Executive Officer and President at Checkpoint Therapeutics, a 230% increase compared to previous year.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$281,250
Salary$450,000
Stock Awards$1,300,000
Total$2,131,250

Oliviero received $1.3M in stock awards, accounting for 61% of the total pay in 2018.

Oliviero also received $100K in bonus, $281.3K in non-equity incentive plan and $450K in salary.

Rankings

In 2018, James F. Oliviero III's compensation ranked 5,389th out of 14,244 executives tracked by ExecPay. In other words, Oliviero earned more than 62.2% of executives.

ClassificationRankingPercentile
All
5,389
out of 14,244
62nd
Division
Manufacturing
2,033
out of 5,765
65th
Major group
Chemicals And Allied Products
743
out of 2,128
65th
Industry group
Drugs
623
out of 1,817
66th
Industry
Pharmaceutical Preparations
479
out of 1,391
66th
Source: SEC filing on April 30, 2019.

Oliviero's colleagues

We found one more compensation record of an executive who worked with James F. Oliviero III at Checkpoint Therapeutics in 2018.

2018

William Gray

Checkpoint Therapeutics

Vice President, Finance and Accounting

News

You may also like